
Sign up to save your podcasts
Or


Life sciences cloud software company Veeva's origins as a highly decentralized organization and its early adoption of video conferencing paid off when Covid-19 forced the switch to remote work. The business was able to help speed up the vaccine pipeline. Co-founder and director, HBS alumnus Matt Wallach, talks about the firm’s post-Covid work-from-anywhere strategy, its embrace of the multi-stakeholder public benefit corporation model, and why it foregoes non-compete clauses as it aims to foster employees’ careers.
By Harvard Business School4.6
102102 ratings
Life sciences cloud software company Veeva's origins as a highly decentralized organization and its early adoption of video conferencing paid off when Covid-19 forced the switch to remote work. The business was able to help speed up the vaccine pipeline. Co-founder and director, HBS alumnus Matt Wallach, talks about the firm’s post-Covid work-from-anywhere strategy, its embrace of the multi-stakeholder public benefit corporation model, and why it foregoes non-compete clauses as it aims to foster employees’ careers.

385 Listeners

1,166 Listeners

1,474 Listeners

148 Listeners

170 Listeners

1,105 Listeners

198 Listeners

1,384 Listeners

9,143 Listeners

175 Listeners

825 Listeners

673 Listeners

221 Listeners

81 Listeners

169 Listeners